|
| Exchange Received Time 22/10/2018 13:38:33 Exchange Disseminated Time 22/10/2018 13:38:39 Time Taken 00:00:06 | With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter and half year ended on 30th September, 2018.
We enclose herewith the following:
a) (i) Consolidated Unaudited Financial Results for the quarter and half year ended on 30th September, 2018.
(ii) Consolidated Statement of Assets and Liabilities as at 30th September, 2018.
b) (i) Standalone Unaudited Financial Results for the quarter and half year ended on 30th September, 2018.
(ii) Standalone Statement of Assets and Liabilities as at 30th September, 2018.
c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results.
d) Press Release.
e) Investor Presentation.
The time of commencement of the Board Meeting was 12:00 noon and the time of conclusion was 1:15 p.m.We request you to kindly take the same on record.
|
|
|